Takeda Pharmaceutical Company Limited announced that at its ordinary general meeting of shareholders held on June 29, 2022 shareholders elected John Maraganore as director. Yoshiaki Fujimori and Kimberly A. Reed were newly elected to Audit and Supervisory Committee Members assumed their respective offices.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,180 JPY | +0.53% |
|
+3.77% | +3.11% |
06-25 | US CDC alerts healthcare providers of increase in dengue cases | RE |
06-25 | Takeda's Cancer Drug Gets European Commission Approval | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.11% | 40.7B | |
+55.95% | 811B | |
+43.62% | 640B | |
-6.98% | 353B | |
+19.08% | 333B | |
+9.05% | 302B | |
+16.30% | 246B | |
+2.41% | 225B | |
+12.47% | 218B | |
+8.91% | 168B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Company Limited Announces Board Appointments